Luiz, Marcus V. S. João; Scavone, Cristoforo 
; Tzanno, Carmen
Source: Hemodialysis International. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcus V. S. João e SCAVONE, Cristoforo e TZANNO, Carmen. The CLOCK trial, a double-blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/Ml plus EDTA 30mg/mL are effective and safe for catheter patency maintenanceamong CKD 5D patients on hemodialysis. Hemodialysis International, v. 21, n. 2, p. 294-304, 2017Tradução . . Disponível em: https://doi.org/10.1111/hdi.12492. Acesso em: 28 set. 2024.APA
Luiz, M. V. S. J., Scavone, C., & Tzanno, C. (2017). The CLOCK trial, a double-blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/Ml plus EDTA 30mg/mL are effective and safe for catheter patency maintenanceamong CKD 5D patients on hemodialysis. Hemodialysis International, 21( 2), 294-304. doi:10.1111/hdi.12492NLM
Luiz MVSJ, Scavone C, Tzanno C. The CLOCK trial, a double-blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/Ml plus EDTA 30mg/mL are effective and safe for catheter patency maintenanceamong CKD 5D patients on hemodialysis [Internet]. Hemodialysis International. 2017 ; 21( 2): 294-304.[citado 2024 set. 28 ] Available from: https://doi.org/10.1111/hdi.12492Vancouver
Luiz MVSJ, Scavone C, Tzanno C. The CLOCK trial, a double-blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/Ml plus EDTA 30mg/mL are effective and safe for catheter patency maintenanceamong CKD 5D patients on hemodialysis [Internet]. Hemodialysis International. 2017 ; 21( 2): 294-304.[citado 2024 set. 28 ] Available from: https://doi.org/10.1111/hdi.12492
